Quarterly Accounts Receivable
$15.10 K
0.00%
30 September 2024
Summary:
Carmell Therapeutics Corporatio quarterly accounts receivable is currently $15.10 thousandOver the past year, it has dropped by -$14.39 million (-99.90%). CTCX quarterly accounts receivable is now -99.90% below its all-time high of $14.40 million, reached on 30 September 2023.CTCX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTCX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -99.9% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CTCX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.9% | at low | ||
| 5 y | 5 years | -99.9% | at low | ||
| alltime | all time | -99.9% | at low |
Carmell Therapeutics Corporatio Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.10 K(-99.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $14.40 M |
FAQ
- What is Carmell Therapeutics Corporatio quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio quarterly accounts receivable year-on-year change?
What is Carmell Therapeutics Corporatio quarterly accounts receivable?
The current quarterly accounts receivable of CTCX is $15.10 K
What is the all time high quarterly accounts receivable for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high quarterly accounts receivable is $14.40 M
What is Carmell Therapeutics Corporatio quarterly accounts receivable year-on-year change?
Over the past year, CTCX quarterly accounts receivable has changed by -$14.39 M (-99.90%)